Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

RSS icon
transplant.jpg

Cancer shortens lifespan of organ transplant patients, especially those receiving a new lung or heart

Nearly 6% of transplant recipients developed cancer within 10 years of the procedure, researchers reported.

September 20, 2021
Old doctor

Updated FDA policy could improve treatment for up to 1.8 million HF patients

Expanded FDA labeling for sacubitril/valsartan could make a massive impact on patient care in the next three years.

September 16, 2021

Risk score predicts new‐onset HF among AFib patients in the ED

The study's authors hope their work can help high-risk patients receive the care they need. 

September 14, 2021
USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older.

Dapagliflozin significantly improves HFpEF symptoms

One researcher described the findings, presented at the Heart Failure Society of America's Annual Scientific Meeting, as "great news for patients and clinicians."

September 13, 2021
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid

Specialists explore relationship between COVID-19 and heart failure, highlighting importance of vaccination

"The rise of the delta variant of COVID-19 is a reminder that this pandemic is not over," the president of the Heart Failure Society of America said in a statement. 

September 1, 2021
Laboratory

Making progress: Heart tissue developed in a laboratory shows promise

These findings, one specialist said, could provide a significant piece to "the puzzle of heart development."

August 27, 2021
COVID-19 vaccines help reduce the serious coronavirus infections and hospitalizations. Multiple studies have shown that the risk from very rare vaccine side effects are far outweighed by the much greater risk of hospitalization and death due to COVID infections.

Risk of heart damage higher after COVID-19 than vaccination

The new analysis, published in the New England Journal of Medicine, included data from more than 2.1 million patients.

August 26, 2021
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.

FDA-approved antiplatelet medication may be an effective heart failure treatment

Additional research is still needed, but researchers may have uncovered a new treatment for heart failure.

August 25, 2021
Displaying 273 - 280 of 906

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup